Oxaliplatin News and Research

RSS
Amgen announces results of two Phase 3 studies evaluating Vectibix for mCRC

Amgen announces results of two Phase 3 studies evaluating Vectibix for mCRC

Access Pharmaceuticals completes enrollment for Prolindac monotherapy trail, begins combination study

Access Pharmaceuticals completes enrollment for Prolindac monotherapy trail, begins combination study

Immune-boosting drug: A new way for improving cancer treatment

Immune-boosting drug: A new way for improving cancer treatment

Cell Therapeutics' platinum-based anti-tumor compounds demonstrate stronger anti-tumor potency

Cell Therapeutics' platinum-based anti-tumor compounds demonstrate stronger anti-tumor potency

Updated clinical data from Poniard Pharmaceuticals' picoplatin Phase 2 trial announced

Updated clinical data from Poniard Pharmaceuticals' picoplatin Phase 2 trial announced

Erbitux recognized as one of the major clinical cancer advances of 2009

Erbitux recognized as one of the major clinical cancer advances of 2009

Amgen announces the results for Phase 3 PRIME '203' trial of Vectibix

Amgen announces the results for Phase 3 PRIME '203' trial of Vectibix

Teva Pharmaceutical Industries net sales up 25%

Teva Pharmaceutical Industries net sales up 25%

Hospira announces fiscal 2009 third-quarter results

Hospira announces fiscal 2009 third-quarter results

Clinical trial helps improve prognosis and changes the standard of care for patients with colorectal cancer

Clinical trial helps improve prognosis and changes the standard of care for patients with colorectal cancer

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Bristol-Myers announces availability of ERBITUX for metastatic colorectal cancer treatment

Bristol-Myers announces availability of ERBITUX for metastatic colorectal cancer treatment

Response Genetics launches new genetic diagnostic test for gastric cancer

Response Genetics launches new genetic diagnostic test for gastric cancer

New method found for the treatment of pancreatic cancer

New method found for the treatment of pancreatic cancer

Results of Phase 3 CRYSTAL study of mCRC patients announced

Results of Phase 3 CRYSTAL study of mCRC patients announced

EGFR-targeted therapy improves survival rates in metastatic colorectal cancer patients

EGFR-targeted therapy improves survival rates in metastatic colorectal cancer patients

Amgen announces Phase 3 results evaluating Vectibix in combination with FOLFIRI chemotherapy

Amgen announces Phase 3 results evaluating Vectibix in combination with FOLFIRI chemotherapy

Amgen to present its four Phase 3 clinical trial results

Amgen to present its four Phase 3 clinical trial results

Abstracts on Merck Serono oncology treatments to be presented at ECCO and ESMO

Abstracts on Merck Serono oncology treatments to be presented at ECCO and ESMO

Discovery of genetic biomarkers enable targeted personalised medication for Colorectal cancer

Discovery of genetic biomarkers enable targeted personalised medication for Colorectal cancer